Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CASCADES: Cashew SLIT in Children
NCT07170540Phase 2Not yet recruiting
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Mar 2027
- Primary completion
- Sep 2029
- Modality
- Allergy Immunotherapy
- Countries
- 1
01
Overview
A Phase 2 trial of cashew sublingual immunotherapy in Cashew Allergy, sponsored by University of North Carolina at Chapel Hill. Planned start Mar 2027; status: not yet recruiting.
02
Drugs
cashew sublingual immunotherapy
03
Conditions
Cashew Allergy
Beyond the preview
Go deeper on NCT07170540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07170540.